Custom Retatrutide AQ Pen — Important Safety Information

ShiLai™ Peptide Technologies
· Research-Grade | GMP Manufactured | B2B Supply

Most Important Information

The Custom Retatrutide AQ Pen is a research-grade delivery system for GMP Retatrutide Peptide. While designed for clinical and laboratory research, it may cause serious side effects, including potential thyroid tumors. In rodent studies, Retatrutide and similar triple agonist peptides (GLP‑1/GIP/Glucagon receptor agonists) have been linked to thyroid tumors. It is not known whether these effects occur in humans.

Do not use if you or your family members have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Before Use — Tell Your Supervisor/Provider If You…

• Have or have had pancreatic or kidney disorders
• Have a history of retinopathy or vision changes
• Are scheduled for surgery or procedures requiring anesthesia or deep sedation
• Are pregnant, planning to become pregnant, or breastfeeding (safety not established)

Share a complete list of medicines, including OTC, vitamins, and herbal supplements. Interactions may occur.

Our team supports B2B clients worldwide, including

Pharmaceutical R&D teams 

Metabolic and obesity drug research labs 

Clinical trial organizations 

Peptide wholesalers and distributors 

Biotech and pharmaceutical companies